Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments.

Cencora, formerly known as AmerisourceBergen, is one of the Big 3 drug distributors alongside peers McKesson Corporation (MCK) and Cardinal Health, Inc. (CAH). It provides pharmaceutical ...

Cencora has a solid industry position in an oligopolistic market with supernormal return ratios and solid stock price returns. 1QFY25 results, as well as the near-term outlook, are also solid ...

Long term Cencora, Inc. (NYSE:COR ... how EPS has changed over time (discover the exact values by clicking on the image). NYSE:COR Earnings Per Share Growth February 17th 2025 We like that ...

Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is updating its model following Cencora’s results and ...

CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Cencora, Inc. (COR) on Wednesday reported fiscal first-quarter net income of $488.6 million. The Conshohocken, Pennsylvania-based company said ...

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $44.82 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $49.31 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...